NASDAQ: XBIO       Xenetic Biosciences Inc
Last Price Today's Change   Day's Range   Trading Volume
1.24   0.00 (0.00%)  0.00 - 0.00  0


Avg Volume (4 weeks):202,480
4 Weeks Range:1.27 - 1.48
4 Weeks Price Volatility (%):
52 Weeks Range:1.27 - 5.68
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Xenetic Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on focused on the discovery, research, and development of next-generation biologic drugs and novel orphan oncology therapeutics. The company’s proprietary drug development platforms include PolyXen, which enables next-generation biologic drugs by improving their half-life and other pharmacological properties. The group’s product candidates include oncology therapeutic XBIO-101 (sodium cridanimod) for the treatment of progesterone resistant endometrial cancer (EC). The firm is based in the United States.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1214  3234  171  7376 

Top 10 Active Counters
 ATVI 82.50+17.11 
 F 24.34-0.85 
 ZNGA 9.05+0.09 
 KSU 293.59-5.05 
 AAPL 170.27-2.80 
 CIT 53.50+2.16 
 SRGA 0.88+0.034 
 AMD 134.565-2.315 
 AMC 18.778-1.792 
 T 27.045-0.135